First American Trust FSB decreased its position in UnitedHealth Group Inc (NYSE:UNH) by 3.5% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 17,713 shares of the healthcare conglomerate’s stock after selling 650 shares during the period. First American Trust FSB’s holdings in UnitedHealth Group were worth $4,413,000 as of its most recent SEC filing.
Several other institutional investors have also recently modified their holdings of UNH. TIAA CREF Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 7.3% during the 3rd quarter. TIAA CREF Investment Management LLC now owns 5,462,680 shares of the healthcare conglomerate’s stock valued at $1,453,291,000 after buying an additional 370,179 shares in the last quarter. Financial Enhancement Group LLC boosted its holdings in shares of UnitedHealth Group by 2,579.3% during the 3rd quarter. Financial Enhancement Group LLC now owns 1,554 shares of the healthcare conglomerate’s stock valued at $413,000 after buying an additional 1,496 shares in the last quarter. Sawtooth Solutions LLC raised its position in shares of UnitedHealth Group by 34.4% in the 3rd quarter. Sawtooth Solutions LLC now owns 4,413 shares of the healthcare conglomerate’s stock worth $1,174,000 after purchasing an additional 1,129 shares during the last quarter. AXA raised its position in shares of UnitedHealth Group by 5.7% in the 3rd quarter. AXA now owns 911,581 shares of the healthcare conglomerate’s stock worth $242,517,000 after purchasing an additional 49,227 shares during the last quarter. Finally, Bluefin Trading LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth about $578,000. Hedge funds and other institutional investors own 85.28% of the company’s stock.
UNH has been the subject of several recent analyst reports. Argus lifted their price target on UnitedHealth Group to $285.00 and gave the stock a “buy” rating in a research report on Thursday, October 18th. Jefferies Financial Group lifted their price target on UnitedHealth Group from $270.00 to $311.00 and gave the stock a “buy” rating in a research report on Wednesday, October 3rd. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, October 2nd. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $299.00 price target for the company in a research report on Tuesday, September 25th. Finally, Bank of America lifted their price target on UnitedHealth Group from $315.00 to $320.00 and gave the stock a “buy” rating in a research report on Wednesday, October 17th. One analyst has rated the stock with a hold rating and twenty-three have given a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and an average target price of $292.33.
Shares of NYSE:UNH opened at $247.67 on Friday. UnitedHealth Group Inc has a fifty-two week low of $208.48 and a fifty-two week high of $287.94. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.61. The stock has a market capitalization of $234.39 billion, a price-to-earnings ratio of 24.59, a price-to-earnings-growth ratio of 1.23 and a beta of 0.88.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The business had revenue of $56.56 billion during the quarter, compared to analyst estimates of $56.34 billion. During the same quarter in the previous year, the firm earned $2.66 EPS. UnitedHealth Group’s revenue was up 12.4% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Inc will post 12.81 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd were given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date was Friday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is 35.75%.
ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group Inc (UNH) Stake Lessened by First American Trust FSB” was posted by Dakota Financial News and is owned by of Dakota Financial News. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://dakotafinancialnews.com/2019/01/12/unitedhealth-group-inc-unh-stake-lessened-by-first-american-trust-fsb.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Hedge Funds Explained
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.